Have a personal or library account? Click to login
Cost of diagnosing and treating cognitive complaints: One-year cost-evaluation study in a patient cohort from a Slovenian memory clinic Cover

Cost of diagnosing and treating cognitive complaints: One-year cost-evaluation study in a patient cohort from a Slovenian memory clinic

Open Access
|Mar 2022

References

  1. Olesen J, Leonardi M. The burden of brain diseases in Europe. Eur J Neurol. 2003;10(5):471-7. doi: 10.1046/j.1468-1331.2003.00682.x.
  2. Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008.
  3. Bon J, Koritnik B, Bresjanac M, Repovš G, Pregelj P, Dobnik B, et al. Cost of disorders of the brain in Slovenia in 2010. Slov Med J. 2013;82(3).
  4. Wimo A, Jönsson L, Bond J, Prince M, Winblad B, Alzheimer disease international: the worldwide economic impact of dementia 2010. Alzheimer’s & Dementia. 2013;9(1):1-11.e3.
  5. Silverman DH, Gambhir SS, Huang H-WC, Schwimmer J, Kim S, Small GW, et al. Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. J Nucl Med. 2002;43(2):253-66.
  6. Kramberger MG. Center for cognitive impairaments, department of neurology, University Medical Centre, Ljubljana. 2021. Accessed 24 April 2021 at: http://www.kobz.si/en/Center%20for%20cognitive%20neurology.php
  7. Wimo A, Gustavsson A, Jönsson L, Winblad B, Hsu M-A, Gannon B. Application of Resource Utilization in Dementia (RUD) instrument in a global setting. Alzheimer’s & dementia. 2013;9(4):429-35. e17. doi: 10.1016/j.jalz.2012.06.008.
  8. Inštitut Republike Slovenije za socialno varstvo. Izvajanje pomoči na domu: analiza stanja v letu 2016. Accessed 3 Oct 2021 at: https://www.irssv.si/upload2/Izvajanje%20PND%20za%20leto%202016_3.pdf
  9. Eurostat. Median hourly earnings. Accessed 3 Oct 2021 at: https://ec.europa.eu/eurostat/databrowser/view/earn_ses_pub2s/default/table?lang=en
  10. Zveza potrošnikov Slovenije. Domovi za starejše 2015. Accessed 3 Oct 2021 at: https://www.zps.si/index.php/trg-in-cene/7279-domovi-zastarejse-3-2015
  11. Jönsson L, Berr C. Cost of dementia in Europe. Eur J Neurol. 2005;12(s1):50-3. doi: 10.1111/j.1468-1331.2005.01190.x.
  12. Wimo A, Religa D, Spangberg K, Edlund AK, Winblad B, Eriksdotter M. Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry. Int J Geriatr Psychiatry. 2013;28(10):1039-44. doi: 10.1002/gps.3925.
  13. Érsek K, Kovács T, Wimo A, Kárpati K, Brodszky V, Péntek M, et al. Costs of dementia in Hungary. J Nutr Health Aging. 2010;14(8):633-9. doi: 10.1007/s12603-010-0309-1.
  14. Holmerová I, Hort J, Rusina R, Wimo A, Šteffl M. Costs of dementia in the Czech Republic. Eur J Health Econ. 2016:1-8. doi: 10.1007/s10198-016-0842-x.
  15. Coduras A, Rabasa I, Frank A, Bermejo-Pareja F, Lopez-Pousa S, Lopez-Arrieta JM, et al. Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer’s disease type in Spain: the ECO study. J Alzheimers Dis. 2010;19(2):601-15. doi: 10.3233/JAD-2010-1258.
  16. Andersen CK, Andersen K, Kragh‐Sørensen P. Cost function estimation: the choice of a model to apply to dementia. Health Econ. 2000;9(5):397409. doi: 10.1002/1099-1050(200007)9:5<;397::aid-hec527>3.0.co;2-e
  17. Mohelska H, Maresova P, Valis M, Kuca K. Alzheimer’s disease and its treatment costs: case study in the Czech Republic. Neuropsychiatr Dis Treat. 2015;11:2349. doi: 10.2147/NDT.S87503.
  18. Alzheimer Europe. Dementia in Europe yearbook 2019 - estimating the prevalence of dementia in Europe 2019 Accessed 5 May 2021 at: https://www.alzheimer-europe.org/Publications/Dementia-in-Europe-Yearbooks
  19. The World Bank. Country and lending groups 2016. Accessed 5 May 2021 at: http://data.worldbank.org/about/country-and-lending-groups
  20. Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina AM, Winblad B, et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimer’s & Dementia. 2017;13(1):1-7.
  21. Hlebec V, Srakar A, Majcen B. Care for the elderly in Slovenia: a combination of informal and formal care. Revija za socijalnu politiku. 2016;23(2):159-79.
  22. Ministrstvo za zdravje RS. Strategija obvladovanja demence v Sloveniji do leta 2020. Accessed 5 May 2021 at: https://www.zod-lj.si/images/Strategija_obvladovanja_demence.pdf
  23. Sedlak S, Lovrenčič M, Jelenc M, Lovrenčič B, Zaletel M, Sambt J. Ekonomske posledice demence v Sloveniji v obdobju 2015-2017. Ljubljana: Nacionalni inštitut za javno zdravje, 2020.
  24. Tomasović S, Sremec J, Košćak J, Klepac N, Draganić P, Bielen I. Epidemiological characteristics of dementia treatment in Croatia. Psychiatria Danubina. 2016;28(2):170-5.
  25. Handels RLH, Wimo A, Dodel R, Kramberger MG, Visser PJ, Molinuevo JL, et al. Cost-utility of using alzheimer’s disease biomarkers in cerebrospinal fluid to predict progression from mild cognitive impairment to dementia. J Alzheimers Dis. 2017;60(4):1477-87. doi: 10.3233/jad-170324.
DOI: https://doi.org/10.2478/sjph-2022-0011 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Language: English
Page range: 76 - 84
Submitted on: Jul 2, 2021
|
Accepted on: Dec 10, 2021
|
Published on: Mar 21, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Eva Županič, Anders Wimo, Bengt Winblad, Milica Gregorič Kramberger, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.